As secondary objectives, we will examine whether these effects are modified by target glucose levels; underlying conditions; dose and route of insulin; glucose level, nutrition, co-medication; and structure of the protocol. We will also investigate the robustness of our estimates by performing ...
and having frequent readings in the 200-300 mg/dl level may be told to keep their fasting and pre-meal blood sugar in the 80-140 mg/dl range, and post-meal blood sugar less than 200 mg/dl. As the patient improves self-management, the target ranges can be tapered down to the usual ...
Secondly, TIR is more accessible and intuitive, enabling patients to know about their blood glucose control level more clearly, encouraging patients to control their diabetes, and helping them improve their blood glucose control with real-time data. Thirdly, TIR is a more accurate assessment of ...
(the Aalst Glycemia Insulin Protocol) were evaluated for achieving a target glucose level of 80 to 110 mg/dL during cardiac surgery and in the intensive... Patrick,Lecomte,Luc,... - 《Survey of Anesthesiology》 被引量: 87发表: 2009年 Glycemic Control in the Intensive Care Unit and during...
Fasting blood glucose HbA1c: Hemoglobin A1c HDL-c: High-density lipoprotein cholesterol HOMA: Homeostasis model assessment estimated insulin resistance IDI: Integrated discrimination improvement IR: Insulin resistance LM: Left main LVEF: Left ventricular ejection fraction MI: Myocardial infarction...
(years; continuous), body mass index (BMI) (< 25, 25–29.9; ≥ 30 kg/m2; and missing data), total cholesterol level (< 200; 200–239; ≥ 240 mg/dL; and missing data), fasting blood glucose level (< 100 and 100–125 mg/dL), smoking status (none-, past-, current...
intensive glucose lowering therapy has been shown to increase the risk of all cause mortality in high-risk patients with type 2 diabetes in ACCORD study.Therefore,the target of blood glucose control should be individualized for each diabetic patient.Not only intensive glucose lowering therapy but ...
Using the pooled placebo group, trend-level differences of moderate effect size were seen (t70 = 1.8, p = 0.079, d = −0.50, Fig. 3, bottom left) for low-dose TS-134. High-dose TS-134 had no significant within or between-group effects on dACC pharmacoBOLD. ...
Traditional treatments for type 1 and type 2 diabetes are often associated with side effects, including weight gain and hypoglycaemia that may offset the benefits of blood glucose lowering. The kidneys filter and reabsorb large amounts of glucose, and urine is almost free of glucose in normoglyc...
To monitor the level of cell death induced by 100 μM NMDA (48 h), a WST assay was used to measure cell viability of the NMDA-treated primary neuronal cultures in the absence or presence of aqueous (upper; Aq) and ethanol (lower; EtOH) extracts of YXT and its selected herbal ...